A founding member of Quinn Emanuel’s appellate practice, Dan Bromberg is an appellate specialist based in Northern California. He has argued before the United States Supreme Court, state courts of final resort, federal courts of appeals, and state intermediate courts of appeals in California and other States. An experienced Supreme Court practitioner, he has filed over three dozen briefs in the Supreme Court, including six successful petitions for certiorari. Mr. Bromberg is also an experienced California appellate lawyer versed in all aspects of California appellate practice who regularly teaches continuing education classes on appellate practice.
Mr. Bromberg is experienced in numerous substantive areas, including patents, trademarks, and other areas of IP law; commercial disputes; antitrust, ERISA, and securities law; transnational disputes; and constitutional law. As a result of the firm’s extensive trial practice, he also has extensive experience with appeals from trials involving multi-million and even billion dollar judgments, successfully overturning a $188 million judgment and reducing another judgment by $200 million as well as successfully defending multi-million dollar verdicts. Mr. Bromberg also recently successfully defended the exclusion of expert testimony seeking over $1 billion in lost profits in a landmark decision by the California Supreme Court establishing that California trial courts have a “gatekeeping” responsibility to exclude expert testimony that is speculative or otherwise unreliable expert testimony.
Mr. Bromberg is rated “AV Preeminent” by Martindale Hubbell, its highest rating, and is a Litigation Counsel of America fellow. He has been recognized as a “Best Lawyer” in appellate practice, an appellate “Super Lawyer,” and a "Top Rated Lawyer in Appellate Law." And he is a certified California appellate law specialist as well as a member of the California Academy of Appellate Lawyers.
Mr. Bromberg’s clients include AIG, Allegheny Energy, Cisco, CNA, DIRECTV, Dole Food Company, Experian, Genentech, IAC/InterActiveCorp, Litton, Micron, Pfizer, RE/MAX, Sprint/Nextel, and TRW as well as numerous individuals and small businesses.